Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure

Conclusions: Rhythm control therapy conveys clinical benefit when initiated within one year of diagnosing atrial fibrillation in patients with signs or symptoms of heart failure. Clinical Trial Registration: Unique Identifiers: ISRCTN04708680, NCT01288352, EudraCT2010-021258-20, Study web site www.easttrial.org; URLs: www.controlled-trials.com; https://clinicaltrials.gov; https://www.clinicaltrialsregister.eu.PMID:34328366 | DOI:10.1161/CIRCULATIONAHA.121.056323

Source: Circulation - July 30, 2021 Category: Cardiology Authors: Andreas Rillig Christina Magnussen Ann-Kathrin Ozga Anna Suling Axel Brandes G ünter Breithardt A John Camm Harry J G M Crijns Lars Eckardt Arif Elvan Andreas Goette Michele Gulizia Laurent Haegeli Hein Heidbuchel Karl-Heinz Kuck Andre Ng Lukasz Szumowsk Source Type: research